Naturally acquired Rift Valley fever virus neutralizing antibodies predominantly target the Gn glycoprotein
Rift Valley fever (RVF) is a viral hemorrhagic disease first discovered in Kenya in 1930. Numerous animal studies have demonstrated that protective immunity is acquired following RVF virus (RVFV) infection and that this correlates with acquisition of virus-neutralizing antibodies (nAbs) that target...
主要な著者: | Wright, D, Allen, ER, Clark, MHA, Gitonga, JN, Karanja, HK, Hulswit, RJG, Taylor, I, Biswas, S, Marshall, J, Mwololo, D, Muriuki, J, Bett, B, Bowden, TA, Warimwe, GM |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Cell Press
2020
|
類似資料
-
Naturally Acquired Rift Valley Fever Virus Neutralizing Antibodies Predominantly Target the Gn Glycoprotein
著者:: Daniel Wright, 等
出版事項: (2020-11-01) -
Rift Valley fever: biology and epidemiology
著者:: Wright, D, 等
出版事項: (2019) -
Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus: evidence for GN-GC glycoprotein heterodimers.
著者:: Huiskonen, J, 等
出版事項: (2009) -
Two monoclonal antibodies against glycoprotein Gn protect mice from Rift Valley Fever challenge by cooperative effects.
著者:: Benjamin Gutjahr, 等
出版事項: (2020-03-01) -
Vaccine Efficacy of Self-Assembled Multimeric Protein Scaffold Particles Displaying the Glycoprotein Gn Head Domain of Rift Valley Fever Virus
著者:: Paul J. Wichgers Schreur, 等
出版事項: (2021-03-01)